PMID- 29961467 OWN - NLM STAT- MEDLINE DCOM- 20180905 LR - 20190501 IS - 2213-3763 (Electronic) IS - 0019-4832 (Print) IS - 0019-4832 (Linking) VI - 70 IP - 3 DP - 2018 May-Jun TI - Intracoronary tenecteplase in STEMI with massive thrombus. PG - 446-449 LID - S0019-4832(17)30140-2 [pii] LID - 10.1016/j.ihj.2017.08.016 [doi] AB - Primary percutaneous coronary intervention is the current standard of care in ST elevation myocardial infarction (STEMI). However, large thrombus is an independent predictor for stent thrombosis and major adverse cardiac events in patients undergoing primary angioplasty for STEMI. Here we report a series of STEMI patients with large thrombus burden treated successfully with low dose intracoronary thrombolysis. There was prompt and early ST resolution. There was improvement in thrombolysis in myocardial infarction (TIMI) flow and myocardial blush grade postlysis in all patients. Majority had recanalised infarct related coronary artery thus obviating the need for stenting. There was no inhospital or 1 month mortality or bleeding events. Hence intracoronary thrombolysis is an option in patients with large thrombus burden. CI - Copyright (c) 2017. Published by Elsevier B.V. FAU - Jayagopal, P B AU - Jayagopal PB AD - Lakshmi Hospital, Palakkad, Kerala, 678013, India. Electronic address: jaigopallakshmi@gmail.com. FAU - Sarjun Basha, Khadhar Mohamed AU - Sarjun Basha KM AD - Department of Cardiology, Lakshmi Hospital, Palakkad, Kerala, 678013, India. LA - eng PT - Case Reports PT - Journal Article DEP - 20170826 PL - India TA - Indian Heart J JT - Indian heart journal JID - 0374675 RN - EC 3.4.21.68 (Tissue Plasminogen Activator) RN - WGD229O42W (Tenecteplase) SB - IM MH - Adult MH - Cardiac Catheterization MH - Coronary Angiography MH - Coronary Thrombosis/*complications/diagnosis/drug therapy MH - Coronary Vessels MH - Dose-Response Relationship, Drug MH - Electrocardiography MH - Female MH - Humans MH - Infusions, Intra-Arterial MH - Male MH - Middle Aged MH - ST Elevation Myocardial Infarction/diagnosis/*drug therapy/etiology MH - Severity of Illness Index MH - Tenecteplase MH - Thrombolytic Therapy/*methods MH - Tissue Plasminogen Activator/*administration & dosage MH - Treatment Outcome PMC - PMC6034014 OTO - NOTNLM OT - Intracoronary thrombolysis OT - Myocardial infarction OT - massive thrombus OT - tenecteplase EDAT- 2018/07/03 06:00 MHDA- 2018/09/06 06:00 PMCR- 2019/05/01 CRDT- 2018/07/03 06:00 PHST- 2017/02/28 00:00 [received] PHST- 2017/08/18 00:00 [revised] PHST- 2017/08/22 00:00 [accepted] PHST- 2018/07/03 06:00 [entrez] PHST- 2018/07/03 06:00 [pubmed] PHST- 2018/09/06 06:00 [medline] PHST- 2019/05/01 00:00 [pmc-release] AID - S0019-4832(17)30140-2 [pii] AID - 10.1016/j.ihj.2017.08.016 [doi] PST - ppublish SO - Indian Heart J. 2018 May-Jun;70(3):446-449. doi: 10.1016/j.ihj.2017.08.016. Epub 2017 Aug 26.